The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Cancer prevention by bovine lactoferrin and underlying mechanisms a review of experimental and clinical studies
Abstract
In experimental studies, bovine lactoferrin (bLF) has been found to significantly inhibit colon, esophagus, lung, and bladder carcinogenesis in rats when administered orally in the post-initiation stage. Furthermore, concomitant administration with carcinogens resulted in inhibition of colon carcinogenesis, possibly by suppression of phase I enzymes, such as cytochrome P450 1A2 (CYP1A2), which is preferentially induced by carcinogenic heterocyclic amines. Enhancement of the activities of their phase II counterparts, such as glutathione S-transferase might have also played a critical role in post-initiation suppression in a study of tongue carcinogenesis. Anti-metastatic effects were moreover detected when bLF was given intragastrically to mice bearing highly metastatic colon carcinoma 26 cells (Co 26Lu), with apparent enhancing influence on local and systemic immunity. Marked increase in the number of cytotoxic T and NK cells in the mucosal layer of the small intestine and peripheral blood cells was thus found, this in turn enhancing the production of Interleukin 18 (IL-18) and caspase-1 in the epithelial cells of the small intestine, with possible consequent induction of interferon (IFN)-γ positive cells. Furthermore, bLF has been found to exert anti-hepatitis C virus (HCV) activity in a preliminary clinical trial in patients with chronic active hepatitis due to this virus, a main causative factor in hepatocellular carcinoma development in Japanese. More extensive clinical trials are now underway in the National Cancer Center Hospital and other institutes to further explore the preventive potential against colon carcinogenesis.Key words: lactoferrin, chemoprevention, colon, carcinogenesis, metastasis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lactoferrin: molecular structure and biological function
Lönnerdal, B., & Iyer, S. (1995) · Annual Review of Nutrition · doi:10.1146/annurev.nu.15.070195.000521 · Cited by 781
Brock, J. H. (2002) · Biochemistry and Cell Biology · doi:10.1139/o01-212 · Cited by 401
The molecular pathways of ultraviolet-induced carcinogenesis
Sarasin, A. (1999) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/s1383-5742(99)00025-3 · Cited by 215
Cited by
Lactoferrin: Multifunctional roles of lactoferrin: a critical overview
Ward, P. P., Paz, E., & Conneely, O. M. (2005) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-005-5369-8 · Cited by 443
Brock, J. H. (2002) · Biochemistry and Cell Biology · doi:10.1139/o01-212 · Cited by 401
Antioxidant properties of Milk and dairy products: A comprehensive review of the current knowledge
Khan, I. T., Nadeem, M., Imran, M., Ullah, R., Ajmal, M., & Jaspal, M. H. (2019) · Lipids in Health and Disease · doi:10.1186/s12944-019-0969-8 · Cited by 374
“Oral administration of lactoferrin derived from bovine milk considerably reduced the risk of several types of cancers [92].”
BackgroundLactoferrin Structure and Functions
Legrand, D., Pierce, A., Elass, E., Carpentier, M., Mariller, C., & Mazurier, J. (2007) · Advances in Experimental Medicine and Biology · doi:10.1007/978-0-387-74087-4_6 · Cited by 293
Twenty-five years of research on bovine lactoferrin applications
TOMITA, M., WAKABAYASHI, H., SHIN, K., YAMAUCHI, K., YAESHIMA, T., & IWATSUKI, K. (2009) · Biochimie · doi:10.1016/j.biochi.2008.05.021 · Cited by 262
Metadata
- Authors
- Tsuda, H., Sekine, K., Fujita, K.-I., & Iigo, M.
- Venue
- Biochemistry and Cell Biology
- Publisher
- Canadian Science Publishing
- Published
- 2002-02-01
- Volume
- 80
- Issue
- 1
- Pages
- 131-136
- ISSN
- 0829-8211 (ISSN-L)
- 1208-6002
- OpenAlex
- W2124503827
- Cited by
- 166
- References
- 3
- FWCI
- 6.17
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Cancer prevention by bovine lactoferrin and underlying mechanisms a review of experimental and clinical studies. https://app.cochat.ai/papers/10.1139/o01-239
- The paper
- Tsuda, H., Sekine, K., Fujita, K.-I., & Iigo, M. (2002). Cancer prevention by bovine lactoferrin and underlying mechanisms a review of experimental and clinical studies. Biochemistry and Cell Biology. https://doi.org/10.1139/o01-239
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.